Interferon alpha-2a and ciprofloxacin synergistically inhibit leukemic cell growth.
Hahn
T
T
Shtalrid
M
M
Berrebi
A
A
Malach
L
L
Barak
Y
Y
Rubinstein
E
E
D001854:Bone Marrow Cells; D002455:Cell Division / Q000187:drug effects*; D002939:Ciprofloxacin / Q000008:administration & dosage*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000494:pharmacology; D006131:Growth Inhibitors; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000473:pathology; D011994:Recombinant Proteins; D014407:Tumor Cells, Cultured
D006131:Growth Inhibitors; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D002939:Ciprofloxacin; D016178:Granulocyte-Macrophage Colony-Stimulating Factor